Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Keryx Biopharmaceuticals, Inc.
(NQ:
KERX
)
8.188
USD
+0.528 (+6.89%)
Streaming Delayed Price
/ Updated:
12:36 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
6,637,759
Open
8.040
Bid (Size)
8.180 (1000)
Ask (Size)
8.190 (2600)
Prev. Close
7.660
Today's Range
8.020 - 8.500
52wk Range
1.680 - 9.980
Shares Outstanding
81,718,058
Dividend Yield
N/A
Top News
More News
Keryx Biopharmaceuticals Rising on Above-Average Volume, Consistent With Trend (KERX)
Today 10:58 EDT
from
Comtex SmarTrend® News Briefs
Notable Analyst Rating Changes 06/19: (CX) (ADBE) (LINE) Upgraded; (CLF) (S) (BBRY) Downgraded
Today 10:30 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8431101 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTEK) Lower (more...)
Today 9:30 EDT
from
StreetInsider.com News Articles
JPMorgan Starts Keryx Biopharmaceuticals (KERX) at Overweight
Today 8:20 EDT
from
StreetInsider.com News Articles
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
June 17, 2013
from
PR Newswire
GSK, AZN, KERX, and RPTP Early Briefing and Review
June 07, 2013
from
ACCESSWIRE
Keryx (KERX) Will Present Updated Zerenex Phase 3 Data
June 03, 2013
from
StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of Nephrology
June 03, 2013
from
PR Newswire
Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31, 2013
category
Stocks
from
Market News Video
Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31, 2013
category
Dividends
from
Dividend Channel
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.